Radiation therapy generates platelet-activating factor agonists

Ravi P. Sahu, Kathleen A. Harrison, Jonathan Weyerbacher, Robert C. Murphy, Raymond Konger, Joy Elizabeth Garrett, Helen Jan Chin-Sinex, Michael Edward Johnston, Joseph Dynlacht, Marc Mendonca, Kevin McMullen, Gengxin Li, Dan Spandau, Jeffrey Travers

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Pro-oxidative stressors can suppress host immunity due to their ability to generate oxidized lipid agonists of the platelet-activating factor-receptor (PAF-R). As radiation therapy also induces reactive oxygen species, the present studies were designed to define whether ionizing radiation could generate PAF-R agonists and if these lipids could subvert host immunity. We demonstrate that radiation exposure of multiple tumor cell lines in-vitro, tumors in-vivo, and human subjects undergoing radiation therapy for skin tumors all generate PAF-R agonists. Structural characterization of radiation-induced PAF-R agonistic activity revealed PAF and multiple oxidized glycerophosphocholines that are produced non-enzymatically. In a murine melanoma tumor model, irradiation of one tumor augmented the growth of the other (non-treated) tumor in a PAF-R-dependent process blocked by a cyclooxygenase-2 inhibitor. These results indicate a novel pathway by which PAF-R agonists produced as a byproduct of radiation therapy could result in tumor treatment failure, and offer important insights into potential therapeutic strategies that could improve the overall antitumor effectiveness of radiation therapy regimens.

Original languageEnglish (US)
Pages (from-to)20788-20800
Number of pages13
JournalOncotarget
Volume7
Issue number15
DOIs
StatePublished - Apr 12 2016

Fingerprint

Platelet Activating Factor
Radiotherapy
Neoplasms
Immunity
Lipids
Cyclooxygenase 2 Inhibitors
Ionizing Radiation
Tumor Cell Line
Treatment Failure
platelet activating factor receptor
Melanoma
Reactive Oxygen Species
Radiation
Skin
Growth

Keywords

  • Antioxidants
  • Cyclooxygenase type 2 enzyme
  • Oxidized glycerophosphocholines
  • Platelet-activating factor
  • Radiation therapy

ASJC Scopus subject areas

  • Oncology

Cite this

Sahu, R. P., Harrison, K. A., Weyerbacher, J., Murphy, R. C., Konger, R., Garrett, J. E., ... Travers, J. (2016). Radiation therapy generates platelet-activating factor agonists. Oncotarget, 7(15), 20788-20800. https://doi.org/10.18632/oncotarget.7878

Radiation therapy generates platelet-activating factor agonists. / Sahu, Ravi P.; Harrison, Kathleen A.; Weyerbacher, Jonathan; Murphy, Robert C.; Konger, Raymond; Garrett, Joy Elizabeth; Chin-Sinex, Helen Jan; Johnston, Michael Edward; Dynlacht, Joseph; Mendonca, Marc; McMullen, Kevin; Li, Gengxin; Spandau, Dan; Travers, Jeffrey.

In: Oncotarget, Vol. 7, No. 15, 12.04.2016, p. 20788-20800.

Research output: Contribution to journalArticle

Sahu, RP, Harrison, KA, Weyerbacher, J, Murphy, RC, Konger, R, Garrett, JE, Chin-Sinex, HJ, Johnston, ME, Dynlacht, J, Mendonca, M, McMullen, K, Li, G, Spandau, D & Travers, J 2016, 'Radiation therapy generates platelet-activating factor agonists', Oncotarget, vol. 7, no. 15, pp. 20788-20800. https://doi.org/10.18632/oncotarget.7878
Sahu RP, Harrison KA, Weyerbacher J, Murphy RC, Konger R, Garrett JE et al. Radiation therapy generates platelet-activating factor agonists. Oncotarget. 2016 Apr 12;7(15):20788-20800. https://doi.org/10.18632/oncotarget.7878
Sahu, Ravi P. ; Harrison, Kathleen A. ; Weyerbacher, Jonathan ; Murphy, Robert C. ; Konger, Raymond ; Garrett, Joy Elizabeth ; Chin-Sinex, Helen Jan ; Johnston, Michael Edward ; Dynlacht, Joseph ; Mendonca, Marc ; McMullen, Kevin ; Li, Gengxin ; Spandau, Dan ; Travers, Jeffrey. / Radiation therapy generates platelet-activating factor agonists. In: Oncotarget. 2016 ; Vol. 7, No. 15. pp. 20788-20800.
@article{96eb6596d5304ccbbb2cedb9dbde37e0,
title = "Radiation therapy generates platelet-activating factor agonists",
abstract = "Pro-oxidative stressors can suppress host immunity due to their ability to generate oxidized lipid agonists of the platelet-activating factor-receptor (PAF-R). As radiation therapy also induces reactive oxygen species, the present studies were designed to define whether ionizing radiation could generate PAF-R agonists and if these lipids could subvert host immunity. We demonstrate that radiation exposure of multiple tumor cell lines in-vitro, tumors in-vivo, and human subjects undergoing radiation therapy for skin tumors all generate PAF-R agonists. Structural characterization of radiation-induced PAF-R agonistic activity revealed PAF and multiple oxidized glycerophosphocholines that are produced non-enzymatically. In a murine melanoma tumor model, irradiation of one tumor augmented the growth of the other (non-treated) tumor in a PAF-R-dependent process blocked by a cyclooxygenase-2 inhibitor. These results indicate a novel pathway by which PAF-R agonists produced as a byproduct of radiation therapy could result in tumor treatment failure, and offer important insights into potential therapeutic strategies that could improve the overall antitumor effectiveness of radiation therapy regimens.",
keywords = "Antioxidants, Cyclooxygenase type 2 enzyme, Oxidized glycerophosphocholines, Platelet-activating factor, Radiation therapy",
author = "Sahu, {Ravi P.} and Harrison, {Kathleen A.} and Jonathan Weyerbacher and Murphy, {Robert C.} and Raymond Konger and Garrett, {Joy Elizabeth} and Chin-Sinex, {Helen Jan} and Johnston, {Michael Edward} and Joseph Dynlacht and Marc Mendonca and Kevin McMullen and Gengxin Li and Dan Spandau and Jeffrey Travers",
year = "2016",
month = "4",
day = "12",
doi = "10.18632/oncotarget.7878",
language = "English (US)",
volume = "7",
pages = "20788--20800",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "15",

}

TY - JOUR

T1 - Radiation therapy generates platelet-activating factor agonists

AU - Sahu, Ravi P.

AU - Harrison, Kathleen A.

AU - Weyerbacher, Jonathan

AU - Murphy, Robert C.

AU - Konger, Raymond

AU - Garrett, Joy Elizabeth

AU - Chin-Sinex, Helen Jan

AU - Johnston, Michael Edward

AU - Dynlacht, Joseph

AU - Mendonca, Marc

AU - McMullen, Kevin

AU - Li, Gengxin

AU - Spandau, Dan

AU - Travers, Jeffrey

PY - 2016/4/12

Y1 - 2016/4/12

N2 - Pro-oxidative stressors can suppress host immunity due to their ability to generate oxidized lipid agonists of the platelet-activating factor-receptor (PAF-R). As radiation therapy also induces reactive oxygen species, the present studies were designed to define whether ionizing radiation could generate PAF-R agonists and if these lipids could subvert host immunity. We demonstrate that radiation exposure of multiple tumor cell lines in-vitro, tumors in-vivo, and human subjects undergoing radiation therapy for skin tumors all generate PAF-R agonists. Structural characterization of radiation-induced PAF-R agonistic activity revealed PAF and multiple oxidized glycerophosphocholines that are produced non-enzymatically. In a murine melanoma tumor model, irradiation of one tumor augmented the growth of the other (non-treated) tumor in a PAF-R-dependent process blocked by a cyclooxygenase-2 inhibitor. These results indicate a novel pathway by which PAF-R agonists produced as a byproduct of radiation therapy could result in tumor treatment failure, and offer important insights into potential therapeutic strategies that could improve the overall antitumor effectiveness of radiation therapy regimens.

AB - Pro-oxidative stressors can suppress host immunity due to their ability to generate oxidized lipid agonists of the platelet-activating factor-receptor (PAF-R). As radiation therapy also induces reactive oxygen species, the present studies were designed to define whether ionizing radiation could generate PAF-R agonists and if these lipids could subvert host immunity. We demonstrate that radiation exposure of multiple tumor cell lines in-vitro, tumors in-vivo, and human subjects undergoing radiation therapy for skin tumors all generate PAF-R agonists. Structural characterization of radiation-induced PAF-R agonistic activity revealed PAF and multiple oxidized glycerophosphocholines that are produced non-enzymatically. In a murine melanoma tumor model, irradiation of one tumor augmented the growth of the other (non-treated) tumor in a PAF-R-dependent process blocked by a cyclooxygenase-2 inhibitor. These results indicate a novel pathway by which PAF-R agonists produced as a byproduct of radiation therapy could result in tumor treatment failure, and offer important insights into potential therapeutic strategies that could improve the overall antitumor effectiveness of radiation therapy regimens.

KW - Antioxidants

KW - Cyclooxygenase type 2 enzyme

KW - Oxidized glycerophosphocholines

KW - Platelet-activating factor

KW - Radiation therapy

UR - http://www.scopus.com/inward/record.url?scp=84964699531&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964699531&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.7878

DO - 10.18632/oncotarget.7878

M3 - Article

C2 - 26959112

AN - SCOPUS:84964699531

VL - 7

SP - 20788

EP - 20800

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 15

ER -